Home›Companies›Biotech & Pharma›XDemics

XDemics Corp

Updated Oct 29, 2026·Latest SEC filing Feb 6, 2026·Suggest an edit

About XDemics

XDemics is a private company based in San Rafael, California. It has reported $14,793,623 raised in three offerings on Form D since June 2024. Its chief executive is Christopher Thanos.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 21, 2025Feb 6, 2026$7,399,999fully sold1$7.3MEquityRule 506(b)Form D ↗
Nov 21, 2024Dec 5, 2024$5,543,624of $7.6M target3$1.8MEquityRule 506(b)Form D ↗
May 30, 2024Jun 12, 2024amended Sep 13, 2024$1,850,000fully sold1$1.8MDebt, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Total, three offerings$14,793,623

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on XDemics's Form D filed Feb 6, 2026.

NB
CC
Colin Cook
Director
CT
Christopher Thanos
Chief Executive Officer and director

Sources

  1. SECXDemics Corp Form D/A, filed Jul 23, 2024
  2. SECXDemics Corp Form D, filed Jun 12, 2024
  3. SECXDemics Corp filing history